Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia

BACKGROUND: Febrile neutropaenia (FN) and resultant infections are the major cause of treatment-related morbidity and mortality in patients receiving chemotherapy. Clinical practice guidelines recommend the use of granulocyte colony-stimulating factors (G-CSF) to reduce the risk of FN and ensuing co...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokane, Lucky L., Bezuidenhout, Selente, Lundie, Maryke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091061/
https://www.ncbi.nlm.nih.gov/pubmed/37064644
http://dx.doi.org/10.4102/hsag.v28i0.2221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091061/
https://www.ncbi.nlm.nih.gov/pubmed/37064644
http://dx.doi.org/10.4102/hsag.v28i0.2221

Ejemplares similares